Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Politics
Pharma
Midterm blue wave brings pharma and MFN under new scrutiny
Pharma leaders should prepare for scrutiny as a blue wave of federal legislators attempt to pry open Trump's MFN deals.
Donavyn Coffey
Nov 12, 2026 2:22pm
CMS locks in Medicare drug price negotiations for the long haul
Nov 6, 2026 4:24pm
WuXi AppTec has performed well in '26 despite US uncertainties
Oct 27, 2026 10:07am
JEC Democrats scrutinize Trump's soaring pharma holdings
Oct 16, 2026 2:50pm
PhRMA pushes back on CMS' Part B MFN model in court
Oct 8, 2026 8:05am
BD snags tariff relief with $19B US investment pledge
Oct 6, 2026 7:42am
